AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32646041 — intervention group
Group type: COMPARATOR
Intervention: Chewing exercises alone (Control)
Number of subjects: 40
Study 35504645 — intervention group
Group type: EXPERIMENTAL
Intervention: Very early invasive coronary angiography (ICA) ± revascularisation
Number of subjects: 425
Study 35504645 — intervention group
Group type: COMPARATOR
Intervention: Standard of care timing of ICA ± revascularisation
Number of subjects: 425
Study 35504645 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac magnetic resonance (CMR) substudy
Number of subjects: 425
Study 34940843 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial participants
Number of subjects: 7091179
Study 35101276 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical bowel preparation (MBP)
Number of subjects: 139
Study 35101276 — intervention group
Group type: COMPARATOR
Intervention: No mechanical bowel preparation (no-MBP)
Number of subjects: 139
Study 34323542 — intervention group
Group type: EXPERIMENTAL
Intervention: Episodic Future Thinking (EFT) intervention
Number of subjects: 89
Study 34323542 — intervention group
Group type: COMPARATOR
Intervention: Control condition (episodic thinking)
Number of subjects: 89
Study 35178208 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (6 mg BD for 3 days)
Number of subjects: 104
Study 35178208 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 33465285 — intervention group
Group type: EXPERIMENTAL
Intervention: ELX-02 at 5.0 mg/kg
Number of subjects: 62
Study 33465285 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 33714510 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibrating platform at a frequency of 30 Hz
Number of subjects: 30
Study 33714510 — intervention group
Group type: COMPARATOR
Intervention: Isometric abdominal exercises without vibration
Number of subjects: 30
Study 33714510 — intervention group
Group type: EXPERIMENTAL
Intervention: Both exercises (with and without vibration)
Number of subjects: 30
Study 32889781 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives (OC)
Number of subjects: 26
Study 32889781 — intervention group
Group type: EXPERIMENTAL
Intervention: High hormone (HH) phase
Number of subjects: 26
Study 35152909 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative oxygenation targets (PaO2 55-80 mmHg)
Number of subjects: 1512
Study 35152909 — intervention group
Group type: COMPARATOR
Intervention: Conventional oxygenation targets (PaO2 110-150 mmHg)
Number of subjects: 1512
Study 34530059 — intervention group
Group type: EXPERIMENTAL
Intervention: SDF (Silver Diamine Fluoride)
Number of subjects: 80
Study 34530059 — intervention group
Group type: COMPARATOR
Intervention: ART (Alternative Restorative Treatment)
Number of subjects: 80
Study 34193435 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative care (PC) service coverage
Number of subjects: 2800
Study 34193435 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral to PC service
Number of subjects: 2800
Study 34193435 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient PC duration
Number of subjects: 2800
Study 34193435 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral to outpatient service
Number of subjects: 2800
Study 34193435 — intervention group
Group type: EXPERIMENTAL
Intervention: PC coverage variation
Number of subjects: 2800
Study 34193435 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictors of lower PC coverage
Number of subjects: 2800
Study 32701720 — intervention group
Group type: EXPERIMENTAL
Intervention: PSMA PET/CT
Number of subjects: 0
Study 32701720 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid PET/MRI
Number of subjects: 0
Study 35151305 — intervention group
Group type: EXPERIMENTAL
Intervention: Working Out Dads (WOD) peer support group intervention
Number of subjects: 280
Study 35151305 — intervention group
Group type: COMPARATOR
Intervention: Usual care (30-min mental health and service focused phone consultation with a health professional)
Number of subjects: 280
Study 34248187 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline injection (10 ml of normal saline) prior to interscalene block
Number of subjects: 36
Study 34248187 — intervention group
Group type: COMPARATOR
Intervention: Conventional group (no saline injection)
Number of subjects: 36
Study 32697978 — intervention group
Group type: EXPERIMENTAL
Intervention: Elongation Index (EI)
Number of subjects: 0
Study 32697978 — intervention group
Group type: COMPARATOR
Intervention: Standard Deformation Index (DI)
Number of subjects: 0
Study 32697978 — intervention group
Group type: EXPERIMENTAL
Intervention: Numerical simulation of mDC experiment
Number of subjects: 0
Study 34051886 — intervention group
Group type: EXPERIMENTAL
Intervention: Same-day screening with Ag-RDT, use of facial masks, and adequate air ventilation during a 5-hour indoor concert.
Number of subjects: 1047
Study 34051886 — intervention group
Group type: COMPARATOR
Intervention: Control group (no attendance at the event).
Number of subjects: 1047
Study 32054791 — intervention group
Group type: EXPERIMENTAL
Intervention: Bladder Training (BT)
Number of subjects: 38
Study 32054791 — intervention group
Group type: COMPARATOR
Intervention: Conservative Advice (CA)
Number of subjects: 38
Study 35965627 — intervention group
Group type: EXPERIMENTAL
Intervention: SMILE
Number of subjects: 600
Study 35965627 — intervention group
Group type: COMPARATOR
Intervention: FS-LASIK
Number of subjects: 600
Study 35965627 — intervention group
Group type: COMPARATOR
Intervention: SBK
Number of subjects: 600
Study 34281485 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based peer support intervention
Number of subjects: 108
Study 34281485 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 108
Study 34893356 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized controlled trial in community health worker recruitment
Number of subjects: 0
Study 32289479 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 g/day valacyclovir
Number of subjects: 88
Study 33563623 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 200
Study 33563623 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 32440936 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended coronally advanced flap (ECAF) associated with acellular dermal matrix graft (ADMG)
Number of subjects: 17
Study 33722999 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromhexine 8 mg four times a day in addition to standard therapy
Number of subjects: 100
Study 33722999 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (lopinavir/ritonavir and interferon beta-1a)
Number of subjects: 100
Study 33309354 — intervention group
Group type: EXPERIMENTAL
Intervention: 0% GH, 24% SBH (0GH)
Number of subjects: 16
Study 33309354 — intervention group
Group type: EXPERIMENTAL
Intervention: 8% GH, 16% SBH (8GH)
Number of subjects: 16
Study 33309354 — intervention group
Group type: EXPERIMENTAL
Intervention: 16% GH, 8% SBH (16GH)
Number of subjects: 16
Study 33309354 — intervention group
Group type: EXPERIMENTAL
Intervention: 24% GH, 0% SBH (24GH)
Number of subjects: 16
Study 32535138 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam Rolling (FR) recovery protocol: five repetitions of 40 s separated by 20 s of rest on calf, quadriceps, hamstrings, and gluteus muscles 5 min after each match.
Number of subjects: 16
Study 32535138 — intervention group
Group type: COMPARATOR
Intervention: Passive Recovery (PR)
Number of subjects: 16
Study 35255973 — intervention group
Group type: EXPERIMENTAL
Intervention: Aloe arborescens fomentation applied after breastfeeding six times per day for 5 days.
Number of subjects: 60
Study 35255973 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group).
Number of subjects: 60
Study 34766835 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal environmental chemical results report
Number of subjects: 295
Study 34766835 — intervention group
Group type: COMPARATOR
Intervention: Only study-wide (aggregate) findings report
Number of subjects: 295
Study 35196591 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% nepafenac eye drops thrice daily for 2 weeks
Number of subjects: 160
Study 35196591 — intervention group
Group type: COMPARATOR
Intervention: 0.09% bromfenac eye drops twice daily for 2 weeks
Number of subjects: 160
Study 35196591 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% nepafenac eye drops
Number of subjects: 160
Study 35196591 — intervention group
Group type: COMPARATOR
Intervention: 0.09% bromfenac eye drops
Number of subjects: 160
Study 34295852 — intervention group
Group type: EXPERIMENTAL
Intervention: Goleghand®
Number of subjects: 60
Study 34295852 — intervention group
Group type: COMPARATOR
Intervention: Polyethylene glycol (PEG)
Number of subjects: 60
Study 35288148 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-L PEG with low-dose ASC (50% lower ASC concentration)
Number of subjects: 215
Study 35288148 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-L PEG with low-dose ASC (25% lower ASC concentration)
Number of subjects: 215
Study 35288148 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-L PEG with low-dose ASC
Number of subjects: 215
Study 33784030 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum TBS (theta burst stimulation)
Number of subjects: 0
Study 33784030 — intervention group
Group type: COMPARATOR
Intervention: Sham TBS
Number of subjects: 0
Study 32382172 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief psychosocial intervention (BPI)
Number of subjects: 66
Study 32382172 — intervention group
Group type: COMPARATOR
Intervention: Nonspecific control intervention
Number of subjects: 66
Study 35144649 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish Oil (FO) at a dose of 3 g/day containing eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)
Number of subjects: 150
Study 35144649 — intervention group
Group type: EXPERIMENTAL
Intervention: Perilla Oil (PO) at a dose of 3 g/day containing α-linolenic acid (ALA)
Number of subjects: 150
Study 35144649 — intervention group
Group type: EXPERIMENTAL
Intervention: Linseed and Fish Oil (LFO) at a dose of 3 g/day containing EPA, DHA, and ALA
Number of subjects: 150
Study 34204498 — intervention group
Group type: EXPERIMENTAL
Intervention: BTE-HE (biphasic truncated exponential high-energy) defibrillator, fixed-energy protocol 200–200–200 J
Number of subjects: 78
Study 34204498 — intervention group
Group type: COMPARATOR
Intervention: PB (pulsed biphasic) defibrillator, fixed-energy protocol 200–200–200 J
Number of subjects: 78
Study 35761557 — intervention group
Group type: EXPERIMENTAL
Intervention: Cellular chickpea-flour with preserved cellular integrity
Number of subjects: 22
Study 35761557 — intervention group
Group type: COMPARATOR
Intervention: Conventional raw-milled chickpea-flour
Number of subjects: 22
Study 33564126 — intervention group
Group type: EXPERIMENTAL
Intervention: Preterm formula (PTF)
Number of subjects: 92
Study 33564126 — intervention group
Group type: COMPARATOR
Intervention: Crossover group (PTF until 40 weeks CGA, then term formula (TF) until 6 months)
Number of subjects: 92
Study 33564126 — intervention group
Group type: EXPERIMENTAL
Intervention: Faster weight gain from term to 12 weeks CGA
Number of subjects: 92
Study 33564126 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant head growth
Number of subjects: 92
Study 32402523 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment Initiation Program (adherence intervention)
Number of subjects: 187
Study 32402523 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (control)
Number of subjects: 187
Study 35449865 — intervention group
Group type: EXPERIMENTAL
Intervention: Early cognitive training combined with aerobic exercise
Number of subjects: 90
Study 35449865 — intervention group
Group type: COMPARATOR
Intervention: Conventional health education combined with rehabilitation training
Number of subjects: 90
Study 34089431 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature-controlled radiofrequency ablation (DT catheter)
Number of subjects: 71
Study 34587217 — intervention group
Group type: EXPERIMENTAL
Intervention: BW-60:60 (body-weight exercises 10x60s with 60s rest)
Number of subjects: 27
Study 34587217 — intervention group
Group type: COMPARATOR
Intervention: SM-20:10 (body-weight exercises 20x20s with 10s rest)
Number of subjects: 27
Study 34587217 — intervention group
Group type: COMPARATOR
Intervention: Ergo-60:60 (cycling 10x60s at 100%Wmax with 60s rest)
Number of subjects: 27
Study 34587217 — intervention group
Group type: COMPARATOR
Intervention: SM-40:20 (body-weight exercises 15x40s with 20s rest)
Number of subjects: 27
Study 34587217 — intervention group
Group type: EXPERIMENTAL
Intervention: BW-60:60
Number of subjects: 27
Study 34587217 — intervention group
Group type: COMPARATOR
Intervention: Ergo-60:60 and BW-60:60
Number of subjects: 27
Study 35281480 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided bilateral transversus thoracic muscle plane block
Number of subjects: 70
Study 35281480 — intervention group
Group type: COMPARATOR
Intervention: Sham block
Number of subjects: 70
Study 32238091 — intervention group
Group type: EXPERIMENTAL
Intervention: MF therapy combined with chemotherapy
Number of subjects: 77
Study 32238091 — intervention group
Group type: COMPARATOR
Intervention: Sham MF therapy combined with chemotherapy
Number of subjects: 77
Study 35263841 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron transdermal system (GTS)
Number of subjects: 389
Study 35263841 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron
Number of subjects: 389
Study 33528751 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracorporeal anastomosis (IA)
Number of subjects: 300
Study 33528751 — intervention group
Group type: COMPARATOR
Intervention: Extracorporeal anastomosis (EA)
Number of subjects: 300
Study 33528751 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracorporeal end‐to‐end anastomosis (IEEA)
Number of subjects: 300
Study 33528751 — intervention group
Group type: COMPARATOR
Intervention: Intracorporeal side‐to‐side anastomosis (ISSA)
Number of subjects: 300
Study 33528751 — intervention group
Group type: EXPERIMENTAL
Intervention: SF‐36 ver.2
Number of subjects: 300
Study 33528751 — intervention group
Group type: EXPERIMENTAL
Intervention: EORTC QLQ‐C30 ver.3
Number of subjects: 300
Study 33528751 — intervention group
Group type: EXPERIMENTAL
Intervention: SURG‐TLX
Number of subjects: 300
Study 33528751 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐year disease‐free survival
Number of subjects: 300
Study 33528751 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 300
Study 33631763 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser haemorrhoidoplasty (LAH)
Number of subjects: 0
Study 33631763 — intervention group
Group type: COMPARATOR
Intervention: Conventional open haemorrhoidectomy (COH)
Number of subjects: 0
Study 33631763 — intervention group
Group type: EXPERIMENTAL
Intervention: Both LAH and COH
Number of subjects: 0
Study 33497537 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan/cilnidipine (80/10 mg)
Number of subjects: 129
Study 33497537 — intervention group
Group type: COMPARATOR
Intervention: Valsartan/hydrochlorothiazide (80/12.5 mg)
Number of subjects: 129
Study 32975088 — intervention group
Group type: EXPERIMENTAL
Intervention: EPF combined with CNRT
Number of subjects: 153
Study 32975088 — intervention group
Group type: COMPARATOR
Intervention: DPF combined with CCRT
Number of subjects: 153
Study 33451263 — intervention group
Group type: EXPERIMENTAL
Intervention: Advance Care Planning Videos
Number of subjects: 241
Study 33451263 — intervention group
Group type: COMPARATOR
Intervention: Control group (no videos)
Number of subjects: 241
Study 32235144 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal analgesic regimen including acetaminophen 1,000 mg, gabapentin 600 mg, ketamine 5 µg/kg/min, and lidocaine 1.5 mg/kg/h
Number of subjects: 299
Study 32235144 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 299
Study 32235144 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal analgesic regimen
Number of subjects: 299
Study 35104665 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (8 mg/kg, monthly intravenous for 6 months)
Number of subjects: 16
Study 35104665 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matching placebo for 6 months)
Number of subjects: 16
Study 35104665 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 16
Study 35104665 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 34802257 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiopulmonary bypass surgery
Number of subjects: 0
Study 32830326 — intervention group
Group type: EXPERIMENTAL
Intervention: Group therapy intervention (12-week duration)
Number of subjects: 52
Study 32830326 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic alliance and number of therapeutic techniques (treatment-specific predictors)
Number of subjects: 52
Study 35371277 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive hand training on the basis of routine rehabilitation treatment (including inducing five finger extension, forcibly pulling fingers and wrist joints, suddenly opening fist after clenching fist)
Number of subjects: 110
Study 35371277 — intervention group
Group type: COMPARATOR
Intervention: Routine rehabilitation treatment (including routine joint activity training, bed training, exercise therapy, and ADL ability training)
Number of subjects: 110
Study 35371277 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive hand training
Number of subjects: 110
Study 35371277 — intervention group
Group type: COMPARATOR
Intervention: Routine rehabilitation treatment
Number of subjects: 110
Study 34289056 — intervention group
Group type: EXPERIMENTAL
Intervention: DNMT3A and DNMT3A/3L
Number of subjects: 0
Study 34289056 — intervention group
Group type: EXPERIMENTAL
Intervention: DNMT3A/3L
Number of subjects: 0
Study 34289056 — intervention group
Group type: EXPERIMENTAL
Intervention: Modeling of DNMT3A/3L
Number of subjects: 0
Study 32193729 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV self-test kits supplied immediately (10 kits)
Number of subjects: 10
Study 32193729 — intervention group
Group type: COMPARATOR
Intervention: HIV self-test kits supplied after 3 months (6 kits)
Number of subjects: 10
Study 35820437 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-sized MCE
Number of subjects: 96
Study 35820437 — intervention group
Group type: COMPARATOR
Intervention: Standard MCE
Number of subjects: 96
Study 33219407 — intervention group
Group type: EXPERIMENTAL
Intervention: Promoting Resilience in Stress Management (PRISM)
Number of subjects: 92
Study 33219407 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 92
Study 33651182 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional group education
Number of subjects: 0
Study 33651182 — intervention group
Group type: COMPARATOR
Intervention: Standard preoperative counseling
Number of subjects: 0
Study 32168780 — intervention group
Group type: EXPERIMENTAL
Intervention: Insoles with polypropylene (58° D Shore)
Number of subjects: 0
Study 32168780 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypropylene with selective aluminium (60 HB Brinell hardness)
Number of subjects: 0
Study 32168780 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethylene vinyl acetate (EVA) (52° A Shore)
Number of subjects: 0
Study 32168780 — intervention group
Group type: COMPARATOR
Intervention: Ordinary EVA (25° A Shore)
Number of subjects: 0
Study 35594274 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 142
Study 33179388 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-week splinting
Number of subjects: 19
Study 33179388 — intervention group
Group type: COMPARATOR
Intervention: Functional splinting time
Number of subjects: 19
Study 32887611 — intervention group
Group type: EXPERIMENTAL
Intervention: Finite element analysis (FEA) with quantized weight-bearing area
Number of subjects: 5
Study 32887611 — intervention group
Group type: COMPARATOR
Intervention: Three different loading surfaces
Number of subjects: 5
Study 35983677 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour change intervention (IG)
Number of subjects: 300
Study 35983677 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 300
Study 32390475 — intervention group
Group type: EXPERIMENTAL
Intervention: MoM THA
Number of subjects: 104
Study 32390475 — intervention group
Group type: COMPARATOR
Intervention: HR
Number of subjects: 104
Study 32252674 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept (IVA) injection followed by panretinal photocoagulation (PRP)
Number of subjects: 34
Study 32252674 — intervention group
Group type: COMPARATOR
Intervention: Early vitrectomy
Number of subjects: 34
Study 36396064 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicultural Healthy Diet (anti-inflammatory dietary pattern)
Number of subjects: 0
Study 36396064 — intervention group
Group type: COMPARATOR
Intervention: Usual diet (control)
Number of subjects: 0
Study 34190207 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy followed by autologous stem cell transplantation (HD-ASCT)
Number of subjects: 140
Study 34190207 — intervention group
Group type: COMPARATOR
Intervention: Whole brain radiation therapy (WBRT)
Number of subjects: 140
Study 32077519 — intervention group
Group type: EXPERIMENTAL
Intervention: V3P-brace
Number of subjects: 24
Study 32077519 — intervention group
Group type: EXPERIMENTAL
Intervention: VER-brace
Number of subjects: 24
Study 32077519 — intervention group
Group type: EXPERIMENTAL
Intervention: ACL-brace
Number of subjects: 24
Study 32077519 — intervention group
Group type: EXPERIMENTAL
Intervention: All three knee braces
Number of subjects: 24
Study 33618016 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers in deprived state (overnight abstinence)
Number of subjects: 102
Study 33618016 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers in satiated state (following smoking reinstatement)
Number of subjects: 102
Study 33618016 — intervention group
Group type: COMPARATOR
Intervention: Nonsmokers (control group)
Number of subjects: 102
Study 33618016 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers (both states)
Number of subjects: 102
Study 34209131 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacogenetic dosing algorithm
Number of subjects: 144
Study 34209131 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care dose adjustment
Number of subjects: 144
Study 33200413 — intervention group
Group type: EXPERIMENTAL
Intervention: PMR (Progressive Muscle Relaxation) delivered via smartphone app
Number of subjects: 139